Archived Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia
Learn about the recent advances as well as the challenges involved in the diagnosis and management of classical hairy cell leukemia (HCL) and HCL-variant.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Recorded Presentation from the NCCN Pharmacy Updates: Updates in Ovarian Cancer - Putting Together the PARP Puzzle and Understanding a New Therapeutic Target
The flurry of changes to the PARPi indications can cause considerable confusion in clinical practice. It may be difficult for health care professionals to keep track of the emerging data and understand how to apply it to patient care. It is important that health care professionals, including pharmacists, are able to educate their patients on the risks vs. benefits of these agents to help empower them to make informed decisions regarding their treatment.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Archived Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas
Learn about the challenges associated with the management of transformed indolent lymphomas and the recent advances in management to help you to incorporate novel therapies into routine clinical practice in the appropriate patient population to improve clinical outcomes.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Updates in the Management of Neuroblastoma
Neuroblastoma is a complex pediatric cancer that can be challenging to treat. It is important to be informed of the updated risk classification system for stratifying those with neuroblastoma, as well as the recommended treatment strategies for each risk group, to ensure optimal outcomes for patients.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Updates in Clinical Management of Pancreatic Cancer
Recent studies delineating molecular alterations in pancreatic cancer and germline alterations in individuals with pancreatic cancer highlight the need to understand the changing landscape of clinical tools available for diagnosing and treating this cancer effectively.
Category
  • Pancreatic Cancer
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates to Treatment of Recurrent/Metastatic Head and Neck Cancers
For patients with widely metastatic head and neck cancer, the goal is palliation or prolongation of life. Recent studies show that immunotherapy provides a reasonable treatment option for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. This presentation will discuss new and emerging treatment options to optimize outcomes for these patients.
Category
  • Head and Neck Cancers
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates in the Management of Small Cell Lung Cancer
For many years, platinum plus etoposide regimens had been recommended for patients with extensive stage small cell lung cancer (SCLC); however, the preferred regimens for extensive stage SCLC now include immune checkpoint inhibitors, either atezolizumab or durvalumab, plus platinum plus etoposide.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
High-Risk Prevention Programs: Identifying Services for High-Risk Patients
The field of risk identification is advancing rapidly through harnessing big data. Understanding this topic is extremely important to help oncology practices understand the data needed to calculate risk and strategies to design successful programs that allow patients to receive appropriate screening and opportunities for early intervention.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
The Evolving Role of Advanced Practice Providers in Oncology Care
Education on this topic is necessary and timely, particularly as the use of advanced practice providers (APPs) is rapidly expanding. There are a variety of models that practices can use to assign work and allocate resources; however, underutilization can result in employee satisfaction issues, high burnout, and wasted resources. This activity provides guidance and best practices on utilization of APPs.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
Successful Team Care Models: Allocation of Responsibilities and Team Metrics
Many care teams struggle to find the right allocation of responsibilities to optimize oncology care team efficiencies. It can be beneficial for oncology care teams to learn from examples of how cancer centers have successfully redesigned care teams and re-allocated responsibilities to decrease provider burnout and provide more efficient, high-quality care.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 1.00 Participation

Pages